McMaster Perspective

  • Once-weekly semaglutide in adults with overweight or obesity

    Once-weekly semaglutide in adults with overweight or obesity

    Dr Megha Poddar, assistant clinical professor at the Faculty of Health Sciences at McMaster University, offers a brief review of new findings on the use of semaglutide in overweight and obesity.

  • COVID-19: April 2021 update. Part 3: Outpatient prophylaxis and treatment

    COVID-19: April 2021 update. Part 3: Outpatient prophylaxis and treatment

    Dr Zain Chagla, associate professor at the Faculty of Health Sciences at McMaster University, comments on COVID-19 prevention and treatment.

  • COVID-19: April 2021 update. Part 2: Vaccines (thrombosis)

    COVID-19: April 2021 update. Part 2: Vaccines (thrombosis)

    Dr Zain Chagla, associate professor at the Faculty of Health Sciences at McMaster University, discusses the reports of thrombotic events following administration of the AstraZeneca vaccine against COVID-19.

  • COVID-19: April 2021 update. Part 1: Vaccines (variants)

    COVID-19: April 2021 update. Part 1: Vaccines (variants)

    Dr Zain Chagla, associate professor at the Faculty of Health Sciences at McMaster University, discusses the efficacy of currently approved COVID-19 vaccines towards different variants of concern.

  • (R)evolution of pharmacologic therapy for diabetes mellitus

    (R)evolution of pharmacologic therapy for diabetes mellitus

    Dr Ally Prebtani, professor of medicine in the Division of Endocrinology and Metabolism at McMaster University, discusses the recently published meta-analysis of the use of SGLT-2 inhibitors and GLP-1 receptor agonists in diabetes.

  • Further progress with tocilizumab in severe COVID-19

    Further progress with tocilizumab in severe COVID-19

    Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University, discusses the latest findings on tocilizumab in the treatment of COVID-19.

  • COVID-19: Remdesivir use and the newest WHO guidelines

    COVID-19: Remdesivir use and the newest WHO guidelines

    Dr Bram Rochwerg, associate professor in the Division of Critical Care and lead author of the WHO/BMJ COVID-19 practice guidelines, discusses the most recent WHO recommendations on remdesivir use.

  • COVID-19: October 9 update. Part 2

    COVID-19: October 9 update. Part 2

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, comments on the current treatment options in COVID-19.

  • COVID-19: October 9 update. Part 1

    COVID-19: October 9 update. Part 1

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the epidemiologic situation in Belgium and current standards of care for ICU patients with COVID-19.

  • COVID-19: Droplets, aerosols, and masks

    COVID-19: Droplets, aerosols, and masks

    Dr Mark Loeb, professor in the Department of Pathology and Molecular Medicine at McMaster University, joins Dr Roman Jaeschke to clarify the difference between droplets vs aerosols and surgical masks vs N95 respirators.

132 articles - page 1 of 14

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.